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A B S T R A C T   
This semi-randomized controlled trial examined the effects of a probiotic food supplement on cortisol and C- 
reactive protein (CRP) in a sample of 262 four-to seven-year-old children (56% girls) in two economically- 
disadvantaged schools in an urban setting in Côte d′Ivoire. For one semester, children in one school were ran-
domized to receive a probiotic (N = 79) or placebo (N = 85) fermented dairy food each day they attended school; 
one child (due to medical reasons) and all children in the other school (N = 98) continued their diets as usual. 
Children provided two saliva samples at 11:30 on consecutive days at the end of the study. Analyses revealed that 
the probiotic group had lower cortisol than the placebo or diet-as-usual groups (p = .015); CRP levels were 
comparable across groups (p = .549). Exploratory analyses suggested that dose and regularity of consumption 
may impact the biomarkers as well. This study provides the first evidence that a probiotic milk product may 
lower cortisol in a sample of young, economically-disadvantaged children.   
1. Introduction 
Stress and inflammation are widely recognized as drivers of poor 
health. They have been associated with immune dysfunction, cardio-
vascular disease, depression, burnout, and stroke (e.g., Furman et al., 
2019; Hammen, 2005; Iacovides et al., 2003; Kivimäki and Kawachi, 
2015; Kivimäki et al., 2013; Lindsberg and Grau, 2003; Mariotti, 2015). 
Research indicates clear links between the gut microbiota (i.e., the 
trillions of microorganisms living in the gastrointestinal tract; e.g., De 
Palma et al., 2015) and both the stress system and systemic inflamma-
tion (Misiak et al., 2020). Probiotics, defined as “live microorganisms 
that, when administered in adequate amounts, confer a health benefit on 
the host,” (Hill et al., 2014) may be a low-cost and accessible means of 
positively impacting the gut and lowering stress and inflammation. 
However, the majority of studies on stress, inflammation, and probiotics 
have been conducted in high income countries in older populations (e.g., 
Zhang et al., 2020). The goal of the present study was to examine 
whether regular consumption of a probiotic food, compared to con-
sumption of a placebo or diet as usual, affects biomarkers of stress and 
inflammation in first-grade children in an urban setting in Abidjan, Côte 
d′Ivoire. 
The study assesses two biomarkers. The first is cortisol, the main 
effector hormone of the hypothalamic-pituitary-adrenal (HPA) axis and 
a well-known marker of stress, which is present in the body at rest and 
elevates in stressful situations. Broadly, cortisol supports health through 
both immunosuppressant and anti-inflammatory roles in the human 
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body (Bellavance and Rivest, 2014; Wamil and Seckl, 2007). Moreover, 
given that most cells in the human body contain cortisol receptors, it is 
thought to play key regulation and support roles for numerous critical 
systems (e.g., the cardiovascular and metabolic systems), as well as 
contributing to cellular health and even fetal development (Jones and 
Gwenin, 2021). When stress is chronic (such as it is in low socioeco-
nomic conditions), cortisol can become permanently elevated, or in 
cases of extreme stress (e.g., child maltreatment), permanently blunted 
(Doom and Gunnar, 2013; Young et al., 2020). Higher concentrations of 
cortisol (measured in hair and saliva) have been associated with car-
diovascular risk, depression, and cognitive deficits linked to changes in 
hippocampal structure (Abell et al., 2016; Kuehl et al., 2015; Lupien 
et al., 1998). Although the mechanisms underlying many of these links 
are as yet unclear, studies point to cortisol-induced structural changes in 
vital organs, such as the hippocampal changes previously mentioned 
and increased carotid intima-media thickness in the heart (e.g., 
Tauchmanovà et al., 2002). The second biomarker, C-reactive protein 
(CRP), is an acute-phase protein produced in the liver. CRP supports the 
immune system through many mechanisms, including binding of lyso-
phosphatidylcholine expressed on the surface of dead or dying cells and 
clearing pathogens from the body (Black et al., 2004; Thompson et al., 
1999). It is also a marker of systemic inflammation, which, when 
chronic, is linked with acceleration of neurodegenerative disease, a 
lessened ability to fight infection (in men), psychiatric disorders, and 
lower self-rated physical health (e.g., Cunningham et al., 2009; Dinh 
et al., 2019; Kaspersen et al., 2016; Osimo et al., 2018). 
There is evidence that early life experience influences these bio-
markers. For example, severe trauma in childhood is associated with 
elevated cortisol and CRP in adulthood (e.g., van Dammen et al., 2020). 
Early life stress, including poor nutrition and low socioeconomic status, 
affects the development of the gut microbiota and plays a critical role in 
the development of normative stress responses and health (e.g., Gomaa, 
2020; de Weerth, 2017). Given this, consumption of foods that positively 
affect gut health may combat elevated stress and inflammation and be a 
first step in setting children up for better health later in life. 
Probiotics, which are associated with numerous health benefits (e.g., 
Aponte et al., 2020), have been hypothesized as potential means of 
reducing both stress and inflammation, but the adult-centered literature 
is mixed. Regarding cortisol, some randomized controlled trials (RCTs) 
find probiotic ingestion linked with lower cortisol (e.g., Takada et al., 
2016) while others do not (see Zhang et al., 2020 for a meta-analysis). 
Probiotic use has been associated with lower CRP in unwell pop-
ulations (e.g., Lowe et al., 2020). However, the only study examining 
probiotic use and salivary CRP found no association (Harnett et al., 
2020), perhaps owing to the fact that serum and salivary CRP are not 
reliably linked in adult populations (Pay and Shaw, 2019), although in 
children, they appear to be (e.g., Tvarijonaviciute et al., 2020). 
Importantly, no studies have examined these associations early in 
development when probiotics might have stronger effects, given that 
critical systems such as the HPA axis are still quite malleable to outside 
influence (e.g., Tremblay et al., 2020; see Sudo et al., 2004 for evidence 
in mice). Moreover, the majority of studies examining stress, inflam-
mation, and probiotics have been conducted in WEIRD (white, educated, 
industrialized, rich, and democratic; Henrich et al., 2010) samples, 
limiting their generalizability. Populations in low- and middle-income 
countries (LMICs) have less access to healthcare and, arguably, more 
risks than WEIRD populations. Children in LMICs often face combined 
stressors such as food insecurity and social exclusion from economic 
resources, both of which are associated with higher concentrations of 
cortisol in hair (Ling et al., 2019; Simmons et al., 2019). Other potential 
stressors include poverty, malnutrition, environmental toxins, and sub-
optimal cognitive stimulation (Black et al., 2013; Obradović et al., 2016; 
Walker et al., 2007). Moreover, limited access to indoor flush sanitation 
and early bouts of diarrhea, both common in LMICs, are associated with 
higher CRP in early adulthood (Said-Mohamed et al., 2019). Although 
no studies in LMICs examine probiotic effects on cortisol or CRP 
specifically, work in Sub-Saharan Africa and South America shows other 
health benefits associated with their consumption, such as reduced ab-
sorption of environmental toxins, reduced respiratory infections, and 
shortened duration of acute diarrhea (Bisanz et al., 2014; Basu et al., 
2009; Villena et al., 2012). Given this, and the demonstrated safety of 
probiotic consumption in children of all ages (e.g., van den Nieuwboer 
et al., 2015), examining probiotic effects on biomarkers of stress and 
inflammation in children in high-risk settings is a worthy step in the goal 
of improving health outcomes worldwide. 
The current investigation is a semi-randomized controlled design 
with three arms: probiotic, placebo, and diet-as-usual. It examines 
whether prolonged probiotic food consumption is associated with sali-
vary cortisol and CRP concentrations in first grade children in Côte 
d′Ivoire. We hypothesized that participants who consumed the probiotic 
product over one semester would have lower values of salivary cortisol 
and CRP than participants who consumed a placebo or no product. We 
also present sensitivity analyses examining whether results are consis-
tent controlling for body-mass-index and socioeconomic status. 
2. Method 
2.1. Participants and procedures 
Participants were 3- to 8-year-old children recruited from first-grade 
classes in two closely-situated schools in a low-income district of 
Abidjan, Côte d′Ivoire. All first-grade children were eligible for inclusion 
and were recruited via flyers sent home in backpacks, as well as word of 
mouth and two social events held at the schools. Caregivers provided 
written informed consent for themselves and their children to take part 
in the study; children provided verbal assent prior to each instance of 
data collection. We used a semi-randomized design due to the ethical 
concern of giving some but not all children in a single school a food 
supplement. Children in one school (the experimental school) comprised 
the randomized probiotic and placebo arms; children in the other (the 
control school) comprised the diet-as-usual arm. In the experimental 
school all available children were recruited (Nprobiotic = 87, Nplacebo =
82, NDAU = 1). In the control school, the first 100 children whose 
caregivers consented (NDAU = 100) were included in the study, resulting 
in a total sample of 270 children. 
Demographics were collected through a caregiver interview that 
took place either in-person or via telephone. At baseline (T1; prior to 
randomization) and at outcome (T2; 3–5 months later), children were 
measured and weighed and provided two saliva samples. They also 
completed cognitive measures and provided a fecal sample, neither of 
which are part of current study. 
After baseline data collection, children from one school were 
randomly assigned to receive probiotic (n = 86) or placebo dêguê (n =
83) each day they were in school for 18 weeks (excepting 18 days due to 
holidays, etc.). Children at the other school (and one at the experimental 
school who could not have dairy due to health reasons) (N = 101) fol-
lowed their diets as usual. Medical care was available at no cost to all 
participants during the study. 
The study was approved by the Comité National d′Ethique des Sci-
ences de la Vie et de la Santé in Côte d′Ivoire and the ethics committee of 
the Social Science Faculty of Radboud University in The Netherlands 
(ECSW-2018–085R1). The study was registered: AsPredicted #32143. 
The analyses presented in this paper are secondary to the primary 
registered question concerning probiotic effects on cognition (separate 
manuscript currently under review). Not all variables mentioned in the 
registration were able to be used; analytic techniques were adapted due 
to missing data. 
2.2. Probiotic 
Probiotic and placebo dêguê (a West African fermented milk product 
containing sugar and millet) were produced for this study by a local 
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dêguê -producing company using standard hygiene practices and 40% 
less sugar than the company’s regular recipe. Probiotic dêguê was fer-
mented using a dried bacterial starter culture with Lacticaseibacillus 
rhamnosus yoba 2012 (previously known as Lactobacillus rhamnosus yoba 
2012) and Streptococcus thermophilus C106 (Kort et al., 2015); and pla-
cebo dêguê was made using S. thermophilus C106 alone. Labelled sachets 
containing the ferments were provided to the company by the 
Yoba-for-Life Foundation. Tests performed in the Netherlands confirmed 
that the dried starter culture in the sachets contained the expected 
bacteria. The local dêguê producer was trained on using the Yoba starter 
culture to produce probiotic fermented dêguê . 
Final cell counts were expected to vary between 2 and 9E7 cfu/mL 
for L. rhamnosus yoba 2012 and 0.8–2E9 cfu/mL for S. thermophilus C106 
(Kort et al., 2015, and see Parker et al., 2018 for the bacterial profile of L. 
rhamnosus yoba 2012 in a similar fermented dish). In-country tests of the 
product confirmed that it was safe for consumption. Adult consumers 
reported no difference in the appearance and texture of the two prod-
ucts, but a slightly more sour taste to the probiotic dêguê . 
Dêguê was served in 125 mL cups with a snap-on lid. The containers 
were indistinguishable other than strings of identifying numbers on 
small labels. Dêguê was delivered to schools in coolers on ice and 
distributed in classrooms; children were monitored to ensure they only 
consumed their own dêguê. 
2.3. Measures 
2.3.1. Covariates 
2.3.1.1. Body mass index z-cores. Children’s height, weight, age, and 
gender were used to calculate zBMI using the zscorer package in R, 
which uses WHO Growth References for school aged children and adults 
(de Onis, 2007). 
2.3.1.1.1. Height and weight. Height and weight were taken on the 
day children were first asked to provide a T2 fecal sample. Children 
removed their shoes before both measurements. Height was measured in 
cm using a stadiometer and weight was measured in kg using a digital 
scale. Both measures were taken by a single research assistant. 
2.3.1.1.2. Age and gender. Caregivers reported their child’s gender. 
Schools and caregivers provided birthdays. When reporters only pro-
vided a year, the child’s age was calculated as if their birthday were July 
1 of the year indicated (N = 34). When only a month and year was given, 
the child’s age was calculated as if their birthday were the first day of the 
month and year provided (N = 3). If reporters only provided a month 
and day or only a month, the birthday was considered to be missing. One 
birthday was discarded as it seemed implausible (i.e., parents reported 
an age of 15 years, but the child was clearly much younger). Ages are in 
days on the day each child provided a T2 stool sample (within two weeks 
of providing saliva samples). 
2.3.1.2. Socioeconomic status (SES). Caregivers endorsed which of 20 
household items (e.g., a stove; created in consultation with local re-
searchers) they owned, a common procedure for estimating SES in low- 
income contexts (e.g., Fotso and Kuate-Defo, 2005). Scores are the 
number of items endorsed; higher scores reflect higher SES. 
2.3.2. Product consumption 
2.3.2.1. Dose: total milliliters consumed. Researchers recorded when 
children were present and consumed 125 mL of dêguê . Unfinished 
servings were weighed (in grams); the amount remaining was subtracted 
from 125 to approximate how much was consumed. Scores reflect the 
sum of the total milliliters of dêguê consumed from the first day of the 
intervention until prior to T2 testing (within two weeks of saliva 
collection). 
2.3.2.2. Regularity of consumption. Children were defined as “regular 
consumers” when they consumed some dêguê on at least two days in 
every week it was offered, not including one, prior to testing. This 
variable was scored as regular = 1 and non-regular = 0. 
2.3.3. Salivary biomarkers 
At T1 and T2, children provided two saliva samples on consecutive 
days by spitting into a 25 mL tube labeled with a line, resulting in four 
samples for each child. Saliva collection, which was done by class, al-
ways occurred around 11:30 am, a time when children would have been 
sitting in class for the last hour without food or strenuous physical ac-
tivity. Children were monitored to ensure they only spat in their own 
tube. Immediately after collection, samples were transferred to 1.5 mL 
tubes and transported on ice to a local research facility where they were 
kept at − 20 degrees Celsius. Due to a technical conservation error at the 
lab, 57% of T1 samples, all from the experimental school, were rendered 
unusable and were discarded. At study completion, the remaining saliva 
samples were packed in dry ice and sent to the Netherlands for pro-
cessing. Saliva was processed at the Central Diagnostic Laboratory’s 
Specieel Laboratorium at Utrecht University Medical Center. Only T2 
values are used for the current analyses. 
2.3.3.1. Cortisol. Cortisol in saliva was measured without extraction 
using an in house competitive radio-immunoassay employing a poly-
clonal anticortisol-antibody (K7348). [1,2–3 H(N)]-Hydrocortisone 
(PerkinElmer NET396250UC) was used as a tracer. The lower limit of 
detection was 1.0 nmol/l and inter-assay variation was < 8% at 2.6–31 
nmol/l (n = 45). Intra-assay variation was < 4% (n = 10). 
2.3.3.2. CRP. CRP was measured using the Salivary C-Reactive Protein 
ELISA Generation II (1–2102, Salimetrics, USA). The lower limit of 
detection was 0.2 pmol/L. Inter-assay variation was < 5% at 0.5 – 5.2 
pmol/L (n = 30). Intra-assay variation was < 1,5% at 0.3 – 2.6 pmol/L 
(n = 5). 
2.4. Statistical analyses 
Cortisol and CRP concentrations were averaged over the two T2 
sampling days and used for analyses. Experimental group effects on 
cortisol and CRP values were examined with ANOVAs using complete 
case analysis without covariates. Then, ANCOVAs with SES and zBMI 
scores chosen a priori as covariates were run as sensitivity analyses. We 
had no missing values for cortisol or CRP, but some for SES and zBMI. In 
the probiotic and placebo groups, exploratory analyses examined po-
tential effects of probiotic dose and regularity of consumption using 
regression analyses including group, mL consumed / regularity of con-
sumption, and the group* mL consumed / regularity of consumption 
interaction. These analyses were also run using complete case analysis, 
first without covariates, and then with. 
3. Results 
3.1. Preliminary analyses 
Only children who provided saliva samples at T2 were included in 
the current analyses (N = 263; Nprobiotic = 85, Nplacebo = 79, NDAU = 98;  
Fig. 1), due to loss of T1 samples by the lab. Analyses examining de-
mographic differences between the experimental and control schools 
revealed that control school caregivers had higher SES than experi-
mental school caregivers (Table 1). 
Probiotic or placebo dêguê was provided to experimental school 
participants every weekday from January 14, 2019 to May 15, 2019 
with the exception of 20 days due to production issues, national holi-
days, and school testing days. Children had between 53 and 68 oppor-
tunities to consume dêguê prior to outcome data collection. Of these 
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Fig. 1. Participant consort flow chart.  
Table 1 
Sample demographics and school comparison.   
Sample By Group    
Experimental School Control School   
(n = 262) Probiotic (n = 85) Placebo (n = 79) Diet as Usual (n = 98)  
Variable (range) M (SD) N M (SD) N M (SD) N M (SD) N Test statistica 
Gender 56.11 62.35 48.10 57.14 .17b 
(% girls) 
Age in years 5.97 (0.74) 6.08 (0.88) 5.92 (0.73) 5.94 (0.62) .56c 
(4.01 – 8.86) 226 68 69 89 
SES 9.47 (2.48) 8.64 (2.37) 9.12 (2.39) 10.40 (2.34) -4.69*c 
(3 – 17) 245 76 74 95 
T2 Height in cm 115.38 (6.10) 116.40 (6.90) 114.68 (6.14) 115.07 (5.22) .86c 
(99.90 – 137.20) 253 82 76 95 
T2 Weight in kg 19.46 (2.92) 20.06 (3.50) 19.07 (2.84) 19.24 (2.32) 1.29c 
(13.1 – 34.0) 259 84 77 98 
T2 BMI z-score -0.60 (0.83) -0.52 (0.89) -0.66 (0.86) -0.62 (0.78) .46c 
(− 2.73 to 3.13) 223 68 67 88 
mL degue consumed 4144.96 (1086.22) 4121.84 (990.49) 4169.85 (1186.54)   
(970 – 6344) 164 85 79 
Consistent consumers 26.22% 22.35% 30.37%   
(% consistent) 
T2 Cortisold 8.31 (2.59) 7.64 (2.53) 8.58 (2.50) 8.66 (2.62)  
(1.00 – 18.63) 262 85 79 98 
T2 C-reactive Proteind 3.16 (6.76) 3.27 (6.88) 2.21 (4.52) 3.84 (8.02)  
(.19 – 43.01) 262 85 79 98 
Note. M = Mean. SD = Standard Deviation. SES = socioeconomic status. mL = milliliters. 
a test statistics are for differences between the experimental school and control school. 
b χ2 tests for categorical data. 
c Independent samples t-tests for normally distributed data. 
d Data are means over two sampling days (11.30hs), non-transformed, and winsorized. 
* p < .001 
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opportunities, 33 occurred during a nationwide teacher strike in which 
schools were closed but the research team was present. During the strike, 
the team attempted daily contact to encourage caregivers to bring 
children to school for dêguê . The mean number of days all enrolled 
children consumed dêguê over the whole study period was 33.65 (SD =
10.97; Mprobiotic = 33.64, SD = 10.31; Mplacebo = 33.66, SD = 11.69). 
Experimental groups consumed similar quantities of dêguê (t = − 0.03; 
p = .778) and had a statistically equivalent number of “regular” con-
sumers (χ2 = 1.36, p = .243; Table 1). Children appeared to enjoy the 
product: more than 95% of cups given were finished. No adverse health 
effects of the product were reported. Approximately 12% of the sample 
sought medical care for minor illnesses or injuries. 
Height and weight values were checked for outliers and in-
consistencies. In particular, we examined cases where values indicated 
that children had grown shorter (N = 5), had grown more than 8 cm 
(N = 4), or whose weight changed more than 3 kg (N = 5) from T1 to 
T2. In all cases, if only one value was biologically plausible it was kept 
and the other was marked as missing. In cases where both values were 
plausible or implausible, both were marked as missing. 
T2 Cortisol and CRP (N = 524) values were checked for outliers. All 
values were biologically possible, so extreme values (N = 19) were 
winsorized (i.e., replaced with a value 3 standard deviations above the 
mean; Tukey, 1977). Cortisol values below 1 were set at.99 (N = 4 in all 
T2 samples) and CRP values below.2 were set at.19 (N = 137 in all T2 
samples). Cortisol values, which were normally distributed, were aver-
aged across the two T2 samples (r = 0.38, p = .000) to create a T2 
cortisol score. The distribution of CRP values was highly skewed (> 3) 
for both T2 samples; log transformation resulted in acceptable skew 
values (< 1.1). Log transformed CRP values were averaged across the 
two T2 samples (r = 0.79, p = .000) to create a T2 CRP score. 
Sample characteristics as well as mean T2 cortisol and (untrans-
formed) CRP values are presented in Table 1. 
3.2. Main analyses 
3.2.1. Cortisol 
A one-way ANOVA revealed a group effect on T2 salivary cortisol 
concentrations (F [2259] = 4.25; p = .015). Fisher’s Least Significant 
Difference (LSD) test revealed that children in the probiotic group had 
lower salivary cortisol at T2 than either the placebo or diet as usual 
groups (Table 1; Fig. 2). The difference became marginally significant 
with the inclusion of covariates, perhaps due to loss of sample size (F 
[2203] = 3.03; p = .051). 
3.2.2. CRP 
There were no group effects on T2 log CRP values, with (F [2259] 
=0.60; p = .549) or without (F [2203] =0.59; p = .553) covariates 
(Table 1). 
3.3. Exploratory analyses within experimental groups 
3.3.1. Cortisol 
In a dose response analysis (i.e. with total milliliters consumed), 
group but not dose (nor the interaction of the two) predicted T2 cortisol 
values; placebo group membership predicted higher cortisol (Table 2). 
Analyses examining regularity of consumption revealed main effects of 
regularity (with more regular consumption predicting higher cortisol) 
and group (with placebo group membership predicting higher cortisol), 
but the interaction of regularity and group was not significant (Table 2). 
For both analyses, inclusion of covariates rendered the models non- 
significant. 
3.3.2. CRP 
In dose response analyses, there was a significant interaction be-
tween group and dose. Simple slopes analyses revealed that greater 
consumption of the placebo product was associated with lower T2 CRP 
values (Fig. 3). The model with covariates was not significant. No 
models predicting T2 CRP with regularity of consumption reached sig-
nificance (Table 2). 
4. Discussion 
This is the first study to show a link between probiotic ingestion and 
reduced cortisol in an economically-disadvantaged population of 
Fig. 2. Cortisol means by group. Note. Error bars are standard errors of the 
mean. Significant differences (p < .05) marked with a star. 
Table 2 
Exploratory Regression Analyses Predicting Cortisol and CRP from mL Dêguê 
Consumed and Regularity of Consumption Presented Without and With 
Covariates.   
mL of dêguê consumed  Regularity of 
consumption  
ß b p  ß b p 
T2 Cortisol F (3, 160) ¼ 2.83, p 
¼ .040  
F (3, 160) ¼ 4.60, p 
¼ .004 
Constant  8.10 .000 Constant  8.12 .000 
Group .18 .92 .021 Group .17 .85 .030 
mL consumed .13 .000 .095 Regularity .19 1.11 .013 
Gp*mLc -0.03 .000 .685 Gp*R -0.12 -1.38 .120 
R2 .05   R2 .08   
T2 Cortisol F (5, 117) = 1.15, 
p = .337  
F (5, 117) = 1.64, 
p = .154 
Constant  8.00 .000 Constant  8.02 .000 
SES .02 .02 .847 SES .02 .02 .860 
BMIz .07 .21 .445 BMIz .07 .20 .457 
Group .18 .93 .053 Group .18 .91 .056 
mL consumed .11 .000 .262 Regularity .15 .87 .100 
Gp*mLc -0.04 .000 .675 Gp*R -0.11 -1.21 .248 
R2 .05   R2 .06   
T2 CRP F (3, 160) ¼ 2.67, p 
¼ .050  
F (3, 160) = 1.44, 
p = .234 
Constant  -0.10 .029 Constant  -0.09 .041 
Group -.04 -0.05 .591 Group -.04 -0.04 .621 
mL consumed -0.09 .000 .270 Regularity -0.05 -0.06 .586 
Gp*mLc -0.18 .000 .023 Gp*R -0.15 -0.37 .065 
R2 .05   R2 .03   
T2 CRP F (5, 117) = 1.62, 
p = .1260  
F (5, 117) = 0.81, 
p = .542 
Constant  -0.09 .666 Constant  -0.11 .598 
SES .01 .003 .867 SES .02 .01 .831 
BMIz .12 .07 .200 BMIz .10 .06 .293 
Group -.01 -0.01 .946 Group -.02 -0.02 .860 
mL consumed -0.08 .000 .381 Regularity -0.06 -0.07 .549 
Gp*mLc -0.21 .000 .030 Gp*R -0.14 -0.34 .139 
R2 .07   R2 .03    
Note. ß = standardized regression coefficient; b = regression coefficient; R2 
= total variance explained by the model. #s = numbers. mL = milliliters. CRP 
= C-Reactive Protein. Gp*mLc = group by milliliters consumed interaction. 
Gp*R = group by regularity classification interaction. BMIz = body mass index 
z-scores. Significant models and significant effects within them are bolded. 
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children from a LMIC. One possible underlying mechanism for reducing 
stress could be via the ingested bacteria enhancing the gut barrier 
function. This would then prevent inflammatory mediators from passing 
into the bloodstream and crossing the blood brain barrier where they 
would stimulate HPA axis reactivity and increase cortisol production 
(Misiak et al., 2020). This is supported, albeit by an animal study, in a 
study in which a Lactobacillus farciminis treatment suppressed such 
stress-induced hyperpermeability, thereby attenuating HPA reactivity to 
stressful events (Ait-Belgnaoui et al., 2012). It is possible that a simple 
boost to gut health through semi-regular consumption of a probiotic 
milk product induced similar changes in the current sample. Future in-
vestigations could perform metabolomic analyses to identify compounds 
in the blood that originated from the gut microbiota as well as immune 
markers of inflammation. Discerning mechanisms of probiotic effects on 
stress will advance not just our understanding of the gut-brain link, but 
also of ways to positively capitalize on it for optimal human health. 
The CRP concentrations at the end of the study were comparable 
between groups (Table 1). This null finding is consistent with the only 
other study examining probiotics and salivary CRP (Harnett et al., 
2020). It is possible that probiotic ingestion is unrelated to salivary CRP 
values or that semi-regular consumption was insufficient to reduce 
systemic inflammation. It is also possible that the CRP values in the 
current investigation were influenced by oral health, a known phe-
nomenon that may be more common in countries with lower access to 
dentistry (Szabo and Slavish, 2021). Of note, many children had very 
low levels of CRP suggesting that this may not have been the case and in 
fact, that participants may have been relatively healthy at the outset. A 
study of known malnourished or ill children would reveal if the pro-
biotic supplemented food affects CRP. 
Interestingly, no dose response effect was found on cortisol. It is 
possible that any amount of L. rhamnosus above a certain threshold can 
attenuate cortisol levels. Among the children in the experimental 
groups, those who consumed either product regularly during the study 
had the highest cortisol. It is possible that children from more food 
insecure or stressful households were sent out of the home more often 
and had more opportunities to come to school for a food supplement, 
even during the teacher strike. Note also that the placebo group had 
more regular consumers than the probiotic, which could account in part 
for this seemingly contradictory finding, given that they had higher 
cortisol. 
There was a significant interaction between dose and group pre-
dicting CRP: milliliters of dêguê consumed was associated with lower 
CRP in the placebo group only (Fig. 3). It is possible that the 
S. thermophilus used to ferment the placebo product has undiscovered 
anti-inflammatory properties. However, this organism was also present 
in the probiotic dêguê making it unlikely that this explains the differ-
ence. More likely, it was an effect of chance owing to the high number of 
children with low levels of salivary CRP and the model becoming 
insignificant upon addition of covariates. Replication will be critical to 
confirm the present findings, as will continued research to determine 
dosage and timing effects in diverse populations. 
The current investigation had many strengths. The study was semi- 
randomized, had three arms, and comprised a relatively large, non- 
WEIRD population of children. The probiotic and placebo dêguê were 
well liked and not associated with any adverse effects. The study had 
high retention, with only six children lost to follow-up. We took saliva 
samples at the end of the morning, a moment we knew the children 
would have been inactive for the hour prior, and at the same time on 
both sampling days. Having two assessments on consecutive days helped 
to account for normal daily fluctuations. The study limitations included 
being unable to deliver the probiotic and placebo dêguê as consistently 
as intended due to the teacher strike, and the loss of baseline samples 
preventing examinations across time and baseline group comparison. 
However, groups did not differ on any baseline covariates except SES 
and controlling for SES in the analyses did not greatly impact the cortisol 
results. In addition, we were unable to assess children’s subjective stress 
and health levels due to their young age and difficulties with self- 
reporting discovered during pilot testing. Given that cortisol is linked 
with many facets of functioning, including but not limited to stress, such 
information would help to disentangle mechanisms of effect and should 
be included in future investigations. Limitations are to be expected when 
working in challenging LMIC settings. Nonetheless, future studies 
should endeavor to deliver probiotic products consistently in order to 
fully elucidate their effects, should compare outcome values to a base-
line where possible, and should measure subjective experiences of stress 
and health where possible. 
4.1. Conclusions 
Overall, this study showed that L. rhamnosus Yoba-2012 might lower 
cortisol in young, economically-disadvantaged children. This, combined 
with the finding that the probiotic dêguê was well received and readily 
consumed, shows the potential to harness the benefits of probiotics and 
disseminate them in communities at risk for early life stress. Given their 
affordability and other well researched health benefits, probiotics may 
lead the way to a healthier population, particularly in LMICs. Future 
studies should investigate the full scope of probiotics and other fer-
mented foods on early biomarkers of health with the aim of setting 
children on a positive health trajectory early in life. 
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Kumari, M., 2016. Assessing cortisol from hair samples in a large observational 
cohort: the Whitehall II study. Psychoneuroendocrinology 73, 148–156. https://doi. 
org/10.1016/j.psyneuen.2016.07.214. 
Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., 
Houdeau, E., Fioramonti, J., Bueno, L., Theodorou, V., 2012. Prevention of gut 
leakiness by a probiotic treatment leads to attenuated HPA response to an acute 
psychological stress in rats. Psychoneuroendocrinology 37 (11), 1885–1895. https:// 
doi.org/10.1016/j.psyneuen.2012.03.024. 
Aponte, M., Murru, N., Shoukat, M., 2020. Therapeutic, prophylactic, and functional use 
of probiotics: a current perspective. Front. Microbiol 11. https://doi.org/10.3389/ 
fmicb.2020.562048. 
Basu, S., Paul, D.K., Ganguly, S., Chatterjee, M., Chandra, P.K., 2009. Efficacy of high- 
dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian 
children. J. Clin. Gastroenterol. 43, 208–213. https://doi.org/10.1097/ 
mcg.0b013e31815a5780. 
Bellavance, M., Rivest, S., 2014. The HPA - immune axis and the immunomodulatory 
actions of glucocorticoids in the brain. Front. Immunol. 5, 136. https://doi.org/ 
10.3389/fimmu.2014.00136. 
Bisanz, J.E., Enos, M.K., Mwanga, J.R., Changalucha, J., Burton, J.P., Gloor, G.B., 
Reid, G., 2014. Randomized open-label pilot study of the influence of probiotics and 
the gut microbiome on toxic metal levels in Tanzanian pregnant women and school 
children. mBio 5, e01580–14. https://doi.org/10.1128/mBio.01580-14. 
Black, R.E., Victora, C.G., Walker, S.P., Bhutta, Z.A., Christian, P., de Onis, M., Ezzati, M., 
Grantham-McGregor, S., Katz, J., Martorell, R., Uauy, R., Maternal and Child 
Nutrition Study Group, 2013. Maternal and child undernutrition and overweight in 
low-income and middle-income countries. Lancet 382, 427–451. https://doi.org/ 
10.1016/S0140-6736(13)60937-X. 
Black, S., Kushner, I., Samols, D., 2004. C-reactive protein. J. Biol. Chem. 279, 
48487–48490. https://doi.org/10.1074/jbc.r400025200. 
Cunningham, C., Campion, S., Lunnon, K., Murray, C.L., Woods, J.F., Deacon, R.M., 
Rawlins, J.N., Perry, V.H., 2009. Systemic inflammation induces acute behavioral 
and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 
65, 304–312. https://doi.org/10.1016/j.biopsych.2008.07.024. 
De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A.J., Green, W., Denou, E., 
Silva, M.A., Santacruz, A., Sanz, Y., Surette, M.G., Verdu, E.F., Collins, S.M., 
Bercik, P., 2015. Microbiota and host determinants of behavioural phenotype in 
maternally separated mice. Nat. Commun. 6, 7735. https://doi.org/10.1038/ 
ncomms8735. 
Dinh, K.M., Kaspersen, K.A., Mikkelsen, S., Pedersen, O.B., Petersen, M.S., Thørner, L.W., 
Hjalgrim, H., Rostgaard, K., Ullum, H., Erikstrup, C., 2019. Low-grade inflammation 
is negatively associated with physical Health-Related Quality of Life in healthy 
individuals: results from The Danish Blood Donor Study (DBDS). PloS One 14, 
0214468. https://doi.org/10.1371/journal.pone.0214468. 
Doom, J.R., Gunnar, M.R., 2013. Stress physiology and developmental psychopathology: 
past, present, and future. Dev. Psychopathol. 25, 1359–1373. https://doi.org/ 
10.1017/s0954579413000667. 
Fotso, J.-C., Kuate-Defo, B., 2005. Measuring socioeconomic status in health research in 
developing countries: should we be focusing on households, communities or both? 
Soc. Indic. Res. 72, 189–237. https://doi.org/10.1007/s11205-004-5579-8. 
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., 
Ferrucci, L., Gilroy, D.W., Fasano, A., Miller, G.W., Miller, A.H., Mantovani, A., 
Weyand, C.M., Barzilai, N., Goronzy, J.J., Rando, T.A., Effros, R.B., Lucia, A., 
Kleinstreuer, N., Slavich, G.M., 2019. Chronic inflammation in the etiology of 
disease across the life span. Nat. Med. 25, 1822–1832. https://doi.org/10.1038/ 
s41591-019-0675-0. 
Gomaa, E.Z., 2020. Human gut microbiota/microbiome in health and diseases: a review. 
Antonie Leeuwenhoek 113, 2019–2040. https://doi.org/10.1007/s10482-020- 
01474-7. 
Hammen, C., 2005. Stress and depression. Ann. Rev. Clin. Psychol. 1, 293–319. https:// 
doi.org/10.1146/annurev.clinpsy.1.102803.143938. 
Harnett, J.E., Pyne, D.B., McKune, A.J., Penm, J., Pumpa, K.L., 2021. Probiotic 
supplementation elicits favourable changes in muscle soreness and sleep quality in 
rugby players. J. Sci. Med. Sport 24, 195–199. https://doi.org/10.1016/j. 
jsams.2020.08.005. 
Henrich, J., Heine, S., Norenzayan, A., 2010. The weirdest people in the world? Behav. 
Brain Sci. 33, 61–83. https://doi.org/10.1017/s0140525×0999152x. 
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., 
Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., Sanders, M.E., 2014. The 
International Scientific Association for Probiotics and Prebiotics consensus statement 
on the scope and appropriate use of the term probiotics. Nat. Rev. Gastroenterol. 
Hepatol. 11, 506–514. https://doi.org/10.1038/nrgastro.2014.66. 
Iacovides, A., Fountoulakis, K.N., Kaprinis, S., Kaprinis, G., 2003. The relationship 
between job stress, burnout and clinical depression. J. Affect. Disord. 75, 209–221. 
https://doi.org/10.1016/s0165-0327(02)00101-5. 
Jones, C., Gwenin, C., 2021. Cortisol level dysregulation and its prevalence - is it nature’s 
alarm clock? Physiol. Rep. 8, 14644. https://doi.org/10.14814/phy2.14644. 
Kaspersen, K.A., Dinh, K.M., Erikstrup, L.T., Burgdorf, K.S., Pedersen, O.B., Sørensen, E., 
Petersen, M.S., Hjalgrim, H., Rostgaard, K., Nielsen, K.R., Ullum, H., Erikstrup, C., 
2016. Low-grade inflammation is associated with susceptibility to infection in 
healthy men: Results from the Danish Blood Donor Study (DBDS). PLoS One 11, 
0164220. https://doi.org/10.1371/journal.pone.0164220. 
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